Related Experiment Video

Updated: Oct 7, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.8K

Hereditary Hemochromatosis: A Cardiac Perspective

Pranay K Joshi1, Saawan C Patel2, Devarashetty Shreya3

  • 1Internal Medicine, B.J. Medical College, Ahmedabad, IND.

Cureus
|January 6, 2022
PubMed

Insights

Hereditary hemochromatosis (HH) can damage the heart due to excess iron. Early detection and management of cardiac involvement in HH are crucial for preventing severe complications and improving patient outcomes.

Area of Science:

  • Cardiology
  • Genetics
  • Metabolic Disorders

Background:

  • Hereditary hemochromatosis (HH) is a common genetic disorder causing iron overload.
  • Iron accumulation in organs like the heart leads to significant damage.
  • Cardiac involvement in HH is underreported, highlighting a need for focused research.

Purpose of the Study:

  • To review existing literature on cardiac hemochromatosis.
  • To emphasize the importance of early diagnosis and management of cardiac complications in HH.
  • To consolidate information on pathogenesis, clinical presentation, diagnosis, and treatment.

Main Methods:

  • Comprehensive literature review of articles and clinical studies on cardiac HH.
  • Compilation and analysis of gathered data on HH-related cardiac issues.
  • Synthesis of information regarding early symptom recognition, diagnostic modalities, and treatment strategies.

Main Results:

  • Cardiac involvement is a serious complication of hereditary hemochromatosis.
  • Early identification of cardiac symptoms and timely intervention are key.
  • Effective management can potentially reverse or prevent further organ damage.

Conclusions:

  • Prompt diagnosis and management of cardiac hemochromatosis are vital for better patient outcomes.
  • Regular monitoring and adherence to treatment are essential for individuals with HH.
  • Further research and clinical attention are needed for cardiac manifestations of HH.

Keywords:
cardiac arrhythmiacardiac hemochromatosishereditary hemochromatosisiron overload cardiomyopathyprimary iron overload

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

5.8K
Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System

Published on: May 5, 2018

11.8K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
85
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
113
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
60
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.6K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
85
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
60